National Biosafety Authority (NBA)

The National Biosafety Authority (NBA) is a government agency in Kenya established under the Biosafety Act, 2009, mandated to regulate the safe development, transfer, handling, and use of genetically modified organisms (GMOs). NBA’s overarching goal is to ensure that biotechnology applications in research, food, feed, trade, and the environment are safe for humans, animals, and ecosystems.

NBA implements a comprehensive regulatory framework through the Biosafety (Environmental Release) Regulations, 2011, Biosafety (Import, Export and Transit) Regulations, 2011, Biosafety (Contained Use) Regulations, 2011, and Biosafety (Labeling) Regulations, 2012. These guidelines provide clear procedures for managing GMOs, ensuring compliance and risk mitigation. The Authority also serves as Kenya’s National Focal Point for the Cartagena Protocol on Biosafety, contributing to the international exchange of scientific and regulatory information.

Key functions include reviewing and approving GMO research and commercialization applications, monitoring ongoing projects, coordinating biosafety research, building national capacity, and promoting public awareness. NBA engages with universities, research institutions, biotechnology companies, and policymakers to support safe innovation while aligning with global best practices.

Beyond regulation, NBA fosters education, stakeholder dialogue, and transparency in biotechnology. Through workshops, training, and outreach programs, it enhances understanding of biosafety risks and benefits among communities and industry players.

With a vision of a nation where GMOs are safe and beneficial, and a mission to facilitate safe biotechnology development, NBA plays a pivotal role in advancing Kenya’s agricultural innovation, protecting public health, and ensuring environmental sustainability.